Evidence map›Paper›PMID 30679581›Full record

ArticleScientific reports2019

Cellular and animal models of skin alterations in the autism-related ADNP syndrome.

Pilar Mollinedo, Oxana Kapitansky, Domingo Gonzalez-Lamuño, Adi Zaslavsky, Pedro Real, Illana Gozes, Alberto Gandarillas, Jose L Fernandez-Luna

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 32 citations in OpenAlex.

  1. Diagnostics (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Article
  4. Moderate Physical Activity Increases the Expression of ADNP in Rat Brain.International journal of molecular sciences · 2024
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Pilar MollinedoGenetics Unit, Hospital Valdecilla, 39008, Santander, Spain.
Oxana KapitanskyDepartment of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Domingo Gonzalez-LamuñoPediatrics Service, Hospital Valdecilla, 39008, Santander, Spain.
Adi ZaslavskyDepartment of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Pedro RealCentro de Genómica e Investigación Oncológica, Universidad de Granada, 18016, Granada, Spain.ORCID 0000-0001-7968-5353
Illana GozesDepartment of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Alberto GandarillasInstituto de Investigación Valdecilla (IDIVAL), 39012, Santander, Spain. agandarillas@idival.org.
Jose L Fernandez-LunaGenetics Unit, Hospital Valdecilla, 39008, Santander, Spain. joseluis.fernandezl@scsalud.es.
Marqués de Valdecilla University Hospital · ESTel Aviv University · ILInstituto de Investigación Marqués de Valdecilla · ESPfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations in ADNP have been recently associated with intellectual disability and autism spectrum disorder. However, the clinical features of patients with this syndrome are not fully identified, and no treatment currently exists for these patients. Here, we extended the ADNP syndrome phenotype describing skin abnormalities in both a patient with ADNP syndrome and an Adnp haploinsufficient mice. The patient displayed thin dermis, hyperkeratotic lesions in periarticular areas and delayed wound healing. Patient-derived skin keratinocytes showed reduced proliferation and increased differentiation. Additionally, detection of cell cycle markers indicated that mutant cells exhibited impaired cell cycle progression. Treatment of ADNP-deficient keratinocytes with the ADNP-derived NAP peptide significantly reduced the expression of differentiation markers. Sonography and immunofluorescence staining of epidermal layers revealed that the dermis was thinner in the patient than in a healthy control. Adnp haploinsufficient mice (Adnp

Indexed as

AnimalsAutism Spectrum DisorderCell CycleCell DifferentiationDisease Models, AnimalHaploinsufficiencyHomeodomain ProteinsHumansIntellectual DisabilityKeratinocytesMiceMice, TransgenicMutationNerve Tissue ProteinsSkin AbnormalitiesWound HealingADNP protein, humanAdnp protein, mouseHomeodomain ProteinsNerve Tissue Proteins

Identifiers

PMID30679581
PMCPMC6346103
OpenAlexW2914564909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.